Perbedaan Organon Pharma Indonesia Tbk. dan Transkon Jaya Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Transkon Jaya Tbk. diperdagangkan di Rp128 (kapitalisasi pasar 196,33 M, volume 24 jam 531,6 rb). Perbedaan utamanya: Transkon Jaya Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TRJA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 196,33 M |
Volume | — | 531,6 rb |
Lot | — | 5,32 rb |
Perputaran | — | 67,73 jt |
Harga Rata-rata | — | 127,4 |
Nilai Transaksi | — | 67,73 jt |
Harga Ekuilibrium Indikatif | — | 128 |
Volume Ekuilibrium Indikatif | — | 5 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Transkon Jaya Tbk (the Company) was established based on the Notarial Deed of Adi Gunawan, SH., No. 27 dated January 4, 2002. The Company started its commercial operations in July2002. The Companys immediate parent company is PT Damai Investa Sukses, incorporated and domiciledin Indonesia.
Selengkapnya di halaman TRJA →